David Lebwohl - Net Worth and Insider Trading
David Lebwohl Net Worth
The estimated net worth of David Lebwohl is at least $1 Million dollars as of 2024-04-28. David Lebwohl is the EVP, Chief Medical Officer of Intellia Therapeutics Inc and owns about 54,372 shares of Intellia Therapeutics Inc (NTLA) stock worth over $1 Million. Details can be seen in David Lebwohl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Lebwohl has not made any transactions after 2024-01-03 and currently still holds the listed stock(s).
Transaction Summary of David Lebwohl
David Lebwohl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Lebwohl owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .
Click here to see the complete history of David Lebwohl’s form 4 insider trades.
Insider Ownership Summary of David Lebwohl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | EVP & Chief Medical Officer |
David Lebwohl Latest Holdings Summary
David Lebwohl currently owns a total of 1 stock. David Lebwohl owns 54,372 shares of Intellia Therapeutics Inc (NTLA) as of January 3, 2024, with a value of $1 Million.
Latest Holdings of David Lebwohl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | 54,372 | 20.76 | 1,128,763 |
Holding Weightings of David Lebwohl
David Lebwohl Form 4 Trading Tracker
According to the SEC Form 4 filings, David Lebwohl has made a total of 8 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 5,843 shares on January 3, 2024, which brought David Lebwohl around $172,135.
Insider Trading History of David Lebwohl
- 1
David Lebwohl Trading Performance
David Lebwohl Ownership Network
Ownership Network List of David Lebwohl
Ownership Network Relation of David Lebwohl
David Lebwohl Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
David Lebwohl is the EVP & Chief Medical Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and EVP & Chief Technical Officer Eliana Clark .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, David Lebwohl made 2 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 8,417. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .
In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
David Lebwohl Mailing Address
Above is the net worth, insider trading, and ownership report for David Lebwohl. You might contact David Lebwohl via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
